BRPI0718351A2 - "processo para a preparação do enantiômero s ou r, processo para formar um composto r ou s, uso de um catalisador quiral, composto, sal tartrato do enantiômero s ou r de um composto, complexo de metal de transição e catalisador" - Google Patents
"processo para a preparação do enantiômero s ou r, processo para formar um composto r ou s, uso de um catalisador quiral, composto, sal tartrato do enantiômero s ou r de um composto, complexo de metal de transição e catalisador"Info
- Publication number
- BRPI0718351A2 BRPI0718351A2 BRPI0718351A BRPI0718351A BRPI0718351A2 BR PI0718351 A2 BRPI0718351 A2 BR PI0718351A2 BR PI0718351 A BRPI0718351 A BR PI0718351A BR PI0718351 A BRPI0718351 A BR PI0718351A BR PI0718351 A2 BRPI0718351 A2 BR PI0718351A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- enantiomer
- catalyst
- preparing
- forming
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86960506P | 2006-12-12 | 2006-12-12 | |
| PCT/GB2007/004756 WO2008071951A2 (en) | 2006-12-12 | 2007-12-12 | Catalytic process for asymmetric hydrogenation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0718351A2 true BRPI0718351A2 (pt) | 2019-09-24 |
Family
ID=39247380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0718351A BRPI0718351A2 (pt) | 2006-12-12 | 2007-12-12 | "processo para a preparação do enantiômero s ou r, processo para formar um composto r ou s, uso de um catalisador quiral, composto, sal tartrato do enantiômero s ou r de um composto, complexo de metal de transição e catalisador" |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8546571B2 (enExample) |
| EP (1) | EP2102182B1 (enExample) |
| JP (1) | JP5372771B2 (enExample) |
| KR (1) | KR20090091326A (enExample) |
| CN (1) | CN101627023A (enExample) |
| AR (1) | AR064308A1 (enExample) |
| AU (1) | AU2007331340A1 (enExample) |
| BR (1) | BRPI0718351A2 (enExample) |
| CA (1) | CA2671830C (enExample) |
| ES (1) | ES2483718T3 (enExample) |
| MX (1) | MX2009006113A (enExample) |
| NO (1) | NO20092259L (enExample) |
| PT (1) | PT103901B (enExample) |
| RU (1) | RU2009126571A (enExample) |
| WO (1) | WO2008071951A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2009126571A (ru) | 2006-12-12 | 2011-01-20 | Биал-Портела Энд Ка, С.А. (Pt) | Каталитический способ асимметричной гидрогенизации |
| GB0709695D0 (en) * | 2007-05-21 | 2007-06-27 | Portela & Ca Sa | Process |
| TW200927740A (en) * | 2007-11-13 | 2009-07-01 | Bial Portela & Ca Sa | Process |
| AR070841A1 (es) * | 2008-03-13 | 2010-05-05 | Bial Portela & Ca Sa | Proceso de hidrogenacion catalitica asimetrica |
| ES2429120T3 (es) * | 2008-03-19 | 2013-11-13 | Bial-Portela & Ca, S.A. | Hidrogenación catalítica asimétrica |
| AR071632A1 (es) * | 2008-05-06 | 2010-06-30 | Bial Portela & Ca Sa | Proceso catalitico para hidrogenacion asimetrica en la sintesis de inhibidores de la dopamina-beta-hidroxilasa" |
| CN111196759B (zh) * | 2018-11-16 | 2023-03-24 | 上海博志研新药物技术有限公司 | 盐酸西那卡塞及其中间体的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202474A (en) | 1989-06-22 | 1993-04-13 | Monsanto Company | Asymmetric catalytic hydrogenation of α-arylpropenoic acids |
| US5420151A (en) | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| BR9507517A (pt) | 1994-04-26 | 1997-09-16 | Syntex Inc | Derivados de benzocicloalquilazotetiona |
| US5886182A (en) * | 1997-12-10 | 1999-03-23 | The Hong Kong Polytechnic University | Chiral pyridylphosphines and their application in asymmetric catalytic hydrogenation of 2-arylpropenoic acids |
| US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| GB0316439D0 (en) * | 2003-07-15 | 2003-08-20 | Johnson Matthey Plc | Catalysts |
| RU2009126571A (ru) | 2006-12-12 | 2011-01-20 | Биал-Портела Энд Ка, С.А. (Pt) | Каталитический способ асимметричной гидрогенизации |
-
2007
- 2007-12-12 RU RU2009126571/04A patent/RU2009126571A/ru not_active Application Discontinuation
- 2007-12-12 CN CN200780051168A patent/CN101627023A/zh active Pending
- 2007-12-12 EP EP07848500.0A patent/EP2102182B1/en not_active Not-in-force
- 2007-12-12 BR BRPI0718351A patent/BRPI0718351A2/pt not_active IP Right Cessation
- 2007-12-12 ES ES07848500.0T patent/ES2483718T3/es active Active
- 2007-12-12 KR KR1020097014315A patent/KR20090091326A/ko not_active Withdrawn
- 2007-12-12 PT PT103901A patent/PT103901B/pt active IP Right Grant
- 2007-12-12 AU AU2007331340A patent/AU2007331340A1/en not_active Abandoned
- 2007-12-12 MX MX2009006113A patent/MX2009006113A/es not_active Application Discontinuation
- 2007-12-12 US US12/518,416 patent/US8546571B2/en not_active Expired - Fee Related
- 2007-12-12 WO PCT/GB2007/004756 patent/WO2008071951A2/en not_active Ceased
- 2007-12-12 CA CA2671830A patent/CA2671830C/en active Active
- 2007-12-12 JP JP2009540851A patent/JP5372771B2/ja not_active Expired - Fee Related
- 2007-12-12 AR ARP070105572A patent/AR064308A1/es unknown
-
2009
- 2009-06-11 NO NO20092259A patent/NO20092259L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007331340A1 (en) | 2008-06-19 |
| KR20090091326A (ko) | 2009-08-27 |
| US8546571B2 (en) | 2013-10-01 |
| ES2483718T3 (es) | 2014-08-07 |
| JP5372771B2 (ja) | 2013-12-18 |
| WO2008071951A3 (en) | 2008-10-02 |
| EP2102182A2 (en) | 2009-09-23 |
| AR064308A1 (es) | 2009-03-25 |
| PT103901B (pt) | 2012-03-01 |
| RU2009126571A (ru) | 2011-01-20 |
| US20100036127A1 (en) | 2010-02-11 |
| EP2102182B1 (en) | 2014-04-23 |
| JP2010512379A (ja) | 2010-04-22 |
| CA2671830C (en) | 2019-03-19 |
| CN101627023A (zh) | 2010-01-13 |
| NO20092259L (no) | 2009-06-25 |
| WO2008071951A2 (en) | 2008-06-19 |
| PT103901A (pt) | 2008-06-12 |
| MX2009006113A (es) | 2009-07-17 |
| CA2671830A1 (en) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0718351A2 (pt) | "processo para a preparação do enantiômero s ou r, processo para formar um composto r ou s, uso de um catalisador quiral, composto, sal tartrato do enantiômero s ou r de um composto, complexo de metal de transição e catalisador" | |
| BRPI0718155A2 (pt) | Composto, uso de um composto, método para tratar doenças mediadas por glk, e, processo para a preparação de um composto. | |
| BRPI0810961A2 (pt) | "processo para a preparação de olefinas e composição catalisadora" | |
| BRPI0908616A2 (pt) | "composto, composição de fluido de perfuração, processo de preparação de um composto de poliamida e uso de um composto" | |
| BRPI0611956A2 (pt) | composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto | |
| BRPI0910734A2 (pt) | composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo. | |
| BRPI1006162A2 (pt) | "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto". | |
| BRPI0717751A2 (pt) | Processo para a fabricação de um composto, composto, e, sal de um composto. | |
| BRPI0816331A2 (pt) | Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto. | |
| BRPI0819869A2 (pt) | processo para a produção de um mosto de cervejeiro, uso de um processo, mosto, e, mistura de enzimas. | |
| PT1896065E (pt) | Processo para a preparação de vacinas | |
| PL1993985T3 (pl) | Sposób wytwarzania 1,2-propanodiolu | |
| BRPI0719024A2 (pt) | Processo para o tratamento de um veícul, processo para a preparação de um catalisador, catalisador e o uso do catalisador | |
| BRPI0915571A2 (pt) | processo para à fabricação de um 1,2-epóxido | |
| BRPI0908252A2 (pt) | Processo para preparar um composto, e, uso de um composto | |
| BRPI0612620A2 (pt) | composição de catalisador, método para a fabricação da mesma, e, processo para a hidrogenação de um composto nitro orgânico ou nitrila na amina correspodente | |
| BRPI0718386A2 (pt) | Processo para preparação de catalisadores. | |
| BRPI0815493A2 (pt) | Composto, uso de um composto, composição faramcêutica, método para a terapia de dor, e, processo para preparar um composto. | |
| BRPI0908738A2 (pt) | composto, medicamento, uso de um composto, e, processo para preparar os compostos | |
| BRPI0815784A2 (pt) | Processo para a preparação de 1,2-propanodiol | |
| BRPI0719706A2 (pt) | Processo para a preparação do 1,3-propanodiol. | |
| BRPI0912163A2 (pt) | Composto químico, processo para a produção de um composto, compsição química, e, uso de um composto químico. | |
| WO2008051539A3 (en) | Processes for preparing palonosetron salts | |
| BRPI0612254A2 (pt) | composto, formulação farmacêutica, combinação, e, processo para preparar um composto | |
| WO2008015558A3 (en) | Beta-3 receptor ligands and their use in therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |